GOLPH3 and colorectal carcinoma: However, these data are at odds with the results from Wang and coauthors [88], showing that high GOLPH3 expression was significantly associated with overall survival in patients who received 5FU-based adjuvant chemotherapy and predicts higher 5-FU sensitivity in LoVo and RKO CRC cell lines.